Oxford Bioscience Partners Company Description
No learned British accent is required at Oxford Bioscience Partners. The venture capital firm invests in biotech and health care companies at all stages of development, but specializes in seed and early-stage enterprises. It typically invests between $1 million to $10 million per transaction and provides assistance to its portfolio companies by taking seats on their boards of directors, recruiting executives, and facilitating corporate partnerships. The company targets firms that utilize information technology or genomics to discover and develop new drug therapies, medical devices, research and development equipment, and other products.
View the Comprehensive Company Description for Oxford Bioscience Partners
The Company Description provides a historical perspective of Oxford Bioscience Partners's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Oxford Bioscience Partners's evolution in the marketplace.
